Revelation Biosciences In... (REVBW)
NASDAQ: REVBW
· Real-Time Price · USD
0.01
-0.00 (-10.71%)
At close: Jun 09, 2025, 2:31 PM
Revelation Biosciences Cash Flow Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -2.05M | -1.73M | -11.22M | -8.39M | -2.68M | -2.2M | -2.63M | -1.45M | 6.16M | -1.21M | -1.17M | -1.83M | -6.62M | -3.86M | -3.04M | -2.47M | -2.61M |
Depreciation & Amortization | 7.22K | 7.22K | 20.7K | 7.22K | 6.26K | 6.26K | 6.26K | 6.26K | 6.26K | 6.26K | 6.26K | 6.26K | 6.26K | 6.26K | 6.07K | 3.81K | 642.00 |
Stock-Based Compensation | 223.46K | 47.57K | 96.28K | 57.09K | 32.09K | 32.09K | 32.1K | 59.44K | 32.09K | 32.36K | 40.67K | 90.19K | 137.89K | 105.91K | 131.32K | 131.32K | 102.33K |
Other Working Capital | n/a | 244.57K | -3.08M | 6.25M | -448.23K | 201.19K | 622.54K | -394.68K | -196.57K | 151.29K | -157.23K | -1.43M | 1.37M | 1.29M | 534.05K | -1.1M | -100.75K |
Other Non-Cash Items | n/a | 22.44K | -1.8M | 467.46K | -345.58K | -52.31K | -29.6K | -423.24K | -7.74M | -716.01K | 503.59K | 647.08K | 14.96K | 14.65K | 14.35K | 14.06K | 9.33K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | -15.89K | -62.96K | n/a | n/a | 716.01K | -503.59K | -647.08K | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | n/a | -2.1M | -1.32M | 5.85M | -126.47K | 229.91K | 965.9K | -185.9K | -27.77K | 221.5K | -607.62K | -1.97M | 1.63M | 854.66K | 658.11K | -1.27M | 118K |
Operating Cash Flow | -2.79M | -3.75M | -14.22M | -2.48M | -2.84M | -2M | -1.72M | -1.99M | -1.58M | -947.47K | -1.73M | -3.71M | -4.83M | -2.88M | -2.23M | -3.59M | -2.38M |
Capital Expenditures | n/a | 17.69K | -17.69K | -19.17K | -19.17K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 16.15K | n/a | -49.02K | -99.1K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -482.87K | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | -281.97K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 525.29K | 281.97K | 71.58K | 134.64K |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -525.29K | n/a | n/a | n/a |
Investing Cash Flow | n/a | 17.69K | -17.69K | -301.14K | -19.17K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 16.15K | 281.97K | -49.02K | -99.1K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -796.88K | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | 5K | n/a | n/a | -5K | n/a | n/a | n/a | -7.65M | -25.7M | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | 3.74M | 5.39M | 127.00 | 14.02M | n/a | 15.00 | 19.00 | n/a | n/a | n/a | 4.28M | n/a | n/a | n/a | n/a |
Financial Cash Flow | n/a | 3.69M | 3.74M | 5.42M | 5.42M | n/a | n/a | 15.00 | 14.02M | 5K | 4.45M | n/a | 10.74M | -24.92M | n/a | n/a | 8M |
Net Cash Flow | -2.79M | -42.03K | -5.53M | -2.48M | 2.56M | -2M | -1.72M | -1.99M | 12.45M | -942.47K | 2.72M | -3.71M | 5.91M | -2.86M | -2.23M | -3.64M | 5.52M |
Free Cash Flow | -2.79M | -3.73M | -14.26M | -2.5M | -2.86M | -2M | -1.72M | -1.99M | -1.58M | -947.47K | -1.73M | -3.71M | -4.83M | -2.86M | -2.23M | -3.64M | -2.48M |